Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia
Immune thrombocytopenia (ITP) is a common acquired autoimmune disease, and thrombopoietin (TPO) is an important cytokine that regulates the production of megakaryocytes and platelets. We have identified a biologically active component, icaritin, from a Chinese herba epimedii extract. Icaritin promot...
Saved in:
Main Authors: | Ke Zhang, Zhenfeng Dai, Runzhe Liu, Fang Tian, Xi Liu, Yi Sun, Xin Zhao, Xiaoping Pu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2018/7235639 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Matthew K. Wun
Published: (2025-01-01) -
Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01) -
Response to letter regarding “Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia”
by: Marjory B. Brooks, et al.
Published: (2025-01-01) -
Clinical Biology and Potential Use of Thrombopoietin
by: Russell Basser
Published: (2000-01-01) -
Correction of Thrombocytopenia with Thrombopoietin Receptor Agonists in Patients with Liver Cirrhosis Before Elective Surgery or Invasive Procedures
by: T. A. Deeva, et al.
Published: (2025-02-01)